the invention relates to a process for solution - phase synthesis of d - arginyl - 2 , 6 - dimethyl - l - tyrosyl - l - lysyl - l - phenylalaninamide , an active ingredient used for both common and rare diseases including a mitochondrial targeted therapy for ischemia reperfusion injury .